Citadel Advisors’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Sell |
|
|||||
|
2025
Q1 | $1.03M | Sell |
|
|||||
|
2024
Q4 | $1.18M | Buy |
|
|||||
|
2024
Q3 | $1.04M | Sell |
|
|||||
|
2024
Q2 | $2.26M | Buy |
|
|||||
|
2024
Q1 | $1.02M | Sell |
|
|||||
|
2023
Q4 | $4.29M | Buy |
|
|||||
|
2023
Q3 | $2.38M | Buy |
|
|||||
|
2023
Q2 | $590K | Buy |
|
|||||
|
2023
Q1 | $216K | Sell |
|
|||||
|
2022
Q4 | $2.36M | Buy |
|
|||||
|
2022
Q3 | $345K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.28M | Sell |
|
|||||
|
2021
Q2 | $2.18M | Buy |
|
|||||
|
2021
Q1 | $815K | Sell |
|
|||||
|
2020
Q4 | $1.01M | Sell |
|
|||||
|
2020
Q3 | $1.85M | Buy |
|
|||||
|
2020
Q2 | $1.3M | Sell |
|
|||||
|
2020
Q1 | $2.62M | Sell |
|
|||||
|
2019
Q4 | $5.89M | Sell |
|
|||||
|
2019
Q3 | $7.05M | Buy |
|
|||||
|
2019
Q2 | $4.48M | Sell |
|
|||||
|
2019
Q1 | $4.85M | Buy |
|
|||||
|
2018
Q4 | $3.06M | Sell |
|
|||||
|
2018
Q3 | $3.99M | Sell |
|
|||||
|
2018
Q2 | $5.07M | Buy |
|
|||||
|
2018
Q1 | $2.33M | Buy |
|
|||||
|
2017
Q4 | $1.88M | Buy |
|
|||||
|
2017
Q3 | $1.41M | Sell |
|
|||||
|
2017
Q2 | $1.69M | Buy |
|
|||||
|
2017
Q1 | $1.41M | Sell |
|
|||||
|
2016
Q4 | $1.99M | Buy |
|
|||||
|
2016
Q3 | $980K | Buy |
|
|||||
|
2016
Q2 | $225K | Sell |
|
|||||
|
2016
Q1 | $1.19M | Buy |
|
|||||
|
2015
Q4 | $574K | Buy |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $228K | Sell |
|
|||||
|
2014
Q4 | $367K | Buy |
|
|||||
|
2014
Q3 | $9K | Sell |
|
|||||
|
2014
Q2 | $1.09M | Sell |
|
|||||
|
2014
Q1 | $981K | Buy |
|
|||||
|
2013
Q4 | $348K | Sell |
|
|||||
|
2013
Q3 | $328K | Buy |
|
|||||
|
2013
Q2 | $232K | Buy |
|